Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Latest News about Schizophrenia Recent news which mentions Schizophrenia Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet August 30, 2024 Tickers BMY EIX LUCY O Tags TRV Market News dividens From Benzinga Promising Milestone: FDA Approves California-Based Trial Assessing MDMA For Schizophrenia June 12, 2023 Tickers PMBHF Tags Schizophrenia Guidance Markets From Benzinga Psychedelics And Schizophrenia: What's The Link? February 19, 2023 Tags Psychedelics General Benzinga From Benzinga Tips on Managing Your Schizophrenia August 22, 2022 Tickers ALKS Tags NASDAQ:ALKS Alkermes Health & Healthcare From 3BL Media: Corporate Social Responsibility, Energy and Health News Marketing & Marijuana: Why Responsibility Is So Important As Psychosis & Schizophrenia Among Youth Rise June 08, 2022 Tickers CBD CURLF Tags marijuana Leafreport Cannabis From Benzinga Addex Expands Pipeline With Selective M4 PAM Program For Schizophrenia & Other Psychotic Disorders April 06, 2022 Tickers ADXN Tags Schizophrenia News Briefs From Benzinga Amid Russia's Invasion On Ukraine, Karuna Therapeutics Withdraws Guidance On Late-Stage Schizophrenia Trial February 24, 2022 Tickers KRTX Tags General Phase 3 Trial KRTX From Benzinga Cannabis Increases Odds Of This Disorder In Teens Despite Infrequent Use February 08, 2022 Tags contributors Benzinga Schizophrenia From Benzinga Alkermes Schizophrenia Med Shows Lower Mean Weight Gain In Early Illness With Schizophrenia February 08, 2022 Tickers ALKS Tags Briefs News Movers From Benzinga Alkermes Highlights Signs and Symptoms of Schizophrenia January 31, 2022 Tags mental health National Institute of Mental Health Alkermes From 3BL Media: Corporate Social Responsibility, Energy and Health News FDA Gives Green Signal To Reviva Pharma's Late-Stage Schizophrenia Trial January 10, 2022 Tickers RVPH Tags General Phase 3 Trial Movers From Benzinga FDA Pushes Review Of BioXcel's Candidate For Agitation Associated With Neuropsychiatric Disorders December 01, 2021 Tickers BTAI Tags General Movers News From Benzinga Neurocrine Pens $2.6B Pact With Sosei Heptares For Neuro Targets November 22, 2021 Tickers NBIX Tags Market News Benzinga Biotech From Benzinga ATAI Life's Schizophrenia Candidate Shows Promising Action In Mid-Stage Study November 01, 2021 Tickers ATAI Tags Health Care Biotech Trading Ideas From Benzinga Teva Reports Encouraging Data From Late-Stage Schizophrenia Trial November 01, 2021 Tickers TEVA Tags Movers Briefs News From Benzinga Minerva Posts Positive Bioequivalence Results For Schizophrenia Candidate Formulations September 30, 2021 Tickers NERV Tags News Briefs Movers From Benzinga Alkermes Announces Launch of 4th Annual Alkermes Pathways Research Awards® Program September 13, 2021 Tickers ALKS Tags Health & Healthcare Philanthropy & Cause Initiatives Alkermes From 3BL Media: Corporate Social Responsibility, Energy and Health News FDA Approves First And Only Twice-Yearly Schizophrenia Drug September 01, 2021 Tickers JNJ Tags FDA Benzinga JNJ From Benzinga Teva-MedinCell's Schizophrenia Treatment Candidate Under FDA Review September 01, 2021 Tickers TEVA Tags Schizophrenia Market News Benzinga From Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.